Sorbitol-penetration enhancer containing vesicles loaded with baicalin for the protection and regeneration of skin injured by oxidative stress and UV radiation.
3T3 Cells
Animals
Cell Line
Cell Movement
/ drug effects
Cell Proliferation
/ drug effects
Chemistry, Pharmaceutical
/ methods
Drug Delivery Systems
Excipients
/ chemistry
Flavonoids
/ administration & dosage
Humans
Mice
Oxidative Stress
/ drug effects
Particle Size
Regeneration
/ drug effects
Skin
/ drug effects
Sorbitol
/ chemistry
Swine
Ultraviolet Rays
/ adverse effects
Wound Healing
/ drug effects
Baicalin
Cell uptake
Phospholipid vesicles
Skin confocal imaging
Sorbitol
UV and oxidative damages
Journal
International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127
Informations de publication
Date de publication:
30 Jan 2019
30 Jan 2019
Historique:
received:
17
09
2018
revised:
19
11
2018
accepted:
19
11
2018
pubmed:
24
11
2018
medline:
11
4
2019
entrez:
24
11
2018
Statut:
ppublish
Résumé
Aiming at improving the protective effects of baicalin on the skin, new highly-biocompatible penetration enhancer containing vesicles (PEVs) were developed by modifying the base formulation of transfersomes with sorbitol, thus obtaining sorbitol-PEVs. An extensive evaluation of the physico-chemical features of both transfersomes and sorbitol-PEVs was carried out. Transfersomes were mainly close-packed, multi-compartment vesicles, while sorbitol-PEVs appeared mostly as single, spherical, unilamellar vesicles. All the vesicles were small in size (∼128 nm) and negatively charged (∼-67 mV), without significant differences between the formulations. The in vitro delivery of baicalin to intact skin showed an improved ability of sorbitol-PEVs to favour the deposition of the flavonoid into the whole skin. In addition, the vesicular formulations protected keratinocytes and fibroblasts from oxidative stress and UV radiation, and promoted cell proliferation and migration, which favoured the closure of skin wound. Cell uptake was promoted as well, especially when sorbitol-PEVs were used.
Identifiants
pubmed: 30468844
pii: S0378-5173(18)30877-9
doi: 10.1016/j.ijpharm.2018.11.053
pii:
doi:
Substances chimiques
Excipients
0
Flavonoids
0
baicalin
347Q89U4M5
Sorbitol
506T60A25R
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
175-183Informations de copyright
Copyright © 2018 Elsevier B.V. All rights reserved.